Cargando…
COVID-associated complications after reconstructive breast surgery: a retrospective cohort study
PURPOSE: The COVID pandemic significantly influenced reconstructive breast surgery regimens. Many surgeries were cancelled or postponed. COVID entails not only respiratory, but also coagulative symptoms. It, therefore, potentially increases the risk of postoperative complications. The incidence of p...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505595/ https://www.ncbi.nlm.nih.gov/pubmed/37507518 http://dx.doi.org/10.1007/s10549-023-07064-1 |
_version_ | 1785106939278000128 |
---|---|
author | Bubberman, J. M. Claessen, J. Feijen, M. M. W. Meesters-Caberg, M. A. J. Van Kuijk, S. M. J. Van der Hulst, R. R. W. J. Tuinder, S. M. H. |
author_facet | Bubberman, J. M. Claessen, J. Feijen, M. M. W. Meesters-Caberg, M. A. J. Van Kuijk, S. M. J. Van der Hulst, R. R. W. J. Tuinder, S. M. H. |
author_sort | Bubberman, J. M. |
collection | PubMed |
description | PURPOSE: The COVID pandemic significantly influenced reconstructive breast surgery regimens. Many surgeries were cancelled or postponed. COVID entails not only respiratory, but also coagulative symptoms. It, therefore, potentially increases the risk of postoperative complications. The incidence of perioperative COVID infection and its influence on postoperative recovery after reconstructive breast surgery is still unknown. METHODS: This dual center retrospective cohort study included patients that underwent reconstructive breast surgery between March 2020 and July 2021. Post-mastectomy autologous or implant-based breast reconstruction (ABR; IBR), as well as post-lumpectomy oncoplastic partial breast reconstruction (PBR) were eligible. Patient data were extracted from electronic medical records. Data regarding COVID-19 infection was collected through a questionnaire. The primary outcome was complication rate. RESULTS: The ABR, IBR and PBR groups consisted of 113 (12 COVID-positive), 41 (2 COVID-positive) and 113 (10 COVID-positive) patients. In the ABR and PBR groups, postoperative complications occurred significantly more often in patients with perioperative COVID-infection. Especially impaired wound healing occurred significantly more often in the ABR and PBR breasts, but also at the donor site of ABR patients with perioperative COVID. CONCLUSION: Perioperative COVID-infection increases susceptibility to complicated wound healing after reconstructive breast surgery. A possible explanation lies in the dysregulation of haemostasis by the virus, and its direct effects on microvasculature. A hypercoagulable state results. We recommend to postpone elective breast surgery for 4–6 weeks after COVID-19 infection. Also, precautionary measures remain important to minimize the risk of perioperative COVID-19 infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10549-023-07064-1. |
format | Online Article Text |
id | pubmed-10505595 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-105055952023-09-19 COVID-associated complications after reconstructive breast surgery: a retrospective cohort study Bubberman, J. M. Claessen, J. Feijen, M. M. W. Meesters-Caberg, M. A. J. Van Kuijk, S. M. J. Van der Hulst, R. R. W. J. Tuinder, S. M. H. Breast Cancer Res Treat Clinical Trial PURPOSE: The COVID pandemic significantly influenced reconstructive breast surgery regimens. Many surgeries were cancelled or postponed. COVID entails not only respiratory, but also coagulative symptoms. It, therefore, potentially increases the risk of postoperative complications. The incidence of perioperative COVID infection and its influence on postoperative recovery after reconstructive breast surgery is still unknown. METHODS: This dual center retrospective cohort study included patients that underwent reconstructive breast surgery between March 2020 and July 2021. Post-mastectomy autologous or implant-based breast reconstruction (ABR; IBR), as well as post-lumpectomy oncoplastic partial breast reconstruction (PBR) were eligible. Patient data were extracted from electronic medical records. Data regarding COVID-19 infection was collected through a questionnaire. The primary outcome was complication rate. RESULTS: The ABR, IBR and PBR groups consisted of 113 (12 COVID-positive), 41 (2 COVID-positive) and 113 (10 COVID-positive) patients. In the ABR and PBR groups, postoperative complications occurred significantly more often in patients with perioperative COVID-infection. Especially impaired wound healing occurred significantly more often in the ABR and PBR breasts, but also at the donor site of ABR patients with perioperative COVID. CONCLUSION: Perioperative COVID-infection increases susceptibility to complicated wound healing after reconstructive breast surgery. A possible explanation lies in the dysregulation of haemostasis by the virus, and its direct effects on microvasculature. A hypercoagulable state results. We recommend to postpone elective breast surgery for 4–6 weeks after COVID-19 infection. Also, precautionary measures remain important to minimize the risk of perioperative COVID-19 infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10549-023-07064-1. Springer US 2023-07-29 2023 /pmc/articles/PMC10505595/ /pubmed/37507518 http://dx.doi.org/10.1007/s10549-023-07064-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Clinical Trial Bubberman, J. M. Claessen, J. Feijen, M. M. W. Meesters-Caberg, M. A. J. Van Kuijk, S. M. J. Van der Hulst, R. R. W. J. Tuinder, S. M. H. COVID-associated complications after reconstructive breast surgery: a retrospective cohort study |
title | COVID-associated complications after reconstructive breast surgery: a retrospective cohort study |
title_full | COVID-associated complications after reconstructive breast surgery: a retrospective cohort study |
title_fullStr | COVID-associated complications after reconstructive breast surgery: a retrospective cohort study |
title_full_unstemmed | COVID-associated complications after reconstructive breast surgery: a retrospective cohort study |
title_short | COVID-associated complications after reconstructive breast surgery: a retrospective cohort study |
title_sort | covid-associated complications after reconstructive breast surgery: a retrospective cohort study |
topic | Clinical Trial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505595/ https://www.ncbi.nlm.nih.gov/pubmed/37507518 http://dx.doi.org/10.1007/s10549-023-07064-1 |
work_keys_str_mv | AT bubbermanjm covidassociatedcomplicationsafterreconstructivebreastsurgeryaretrospectivecohortstudy AT claessenj covidassociatedcomplicationsafterreconstructivebreastsurgeryaretrospectivecohortstudy AT feijenmmw covidassociatedcomplicationsafterreconstructivebreastsurgeryaretrospectivecohortstudy AT meesterscabergmaj covidassociatedcomplicationsafterreconstructivebreastsurgeryaretrospectivecohortstudy AT vankuijksmj covidassociatedcomplicationsafterreconstructivebreastsurgeryaretrospectivecohortstudy AT vanderhulstrrwj covidassociatedcomplicationsafterreconstructivebreastsurgeryaretrospectivecohortstudy AT tuindersmh covidassociatedcomplicationsafterreconstructivebreastsurgeryaretrospectivecohortstudy |